Catholic Medical Mission Board (CMMB) President and CEO Mary Beth Powers Named to Forbes 50 Over 50 List
August 03, 2023 14:09 ET
|
Catholic Medical Mission Board (CMMB)
New York, New York, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Catholic Medical Mission Board (CMMB) President and CEO Mary Beth Powers has been named to the third-annual Forbes 50 over 50 Impact List. This...
RetinalGeniX Technologies Inc. Granted Patent for Patient Home Monitoring and Physician Alert System for Ocular Anatomy
July 28, 2023 13:24 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., July 28, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), this week was granted a patent for its Patient Home Monitoring...
Leadership Aroostook’s Second Graduating Class Creates Operational Plans to Move the County Forward
July 14, 2023 08:05 ET
|
Husson University
BANGOR, MAINE, July 14, 2023 (GLOBE NEWSWIRE) -- Fourteen professionals from 10 different prominent County businesses recently completed Leadership Aroostook, a professional development initiative...
Nacuity Pharmaceuticals Advances Phase 1/2 Clinical Trial Evaluating NPI-002 Intravitreal Implant for the Delay of Cataract Progression
July 11, 2023 09:00 ET
|
Nacuity Pharmaceuticals, Inc.
New clinical site added and early safety signals observed in trial for treatment of ocular disease caused by oxidative stress First cohort is expected to achieve full enrollment by third quarter...
Milltrust International officially launches British Innovation Fund II
July 10, 2023 14:54 ET
|
Milltrust International Group
LONDON, July 10, 2023 (GLOBE NEWSWIRE) -- On Monday 26 June 2023 Milltrust International, a leading sustainability focused investment firm, officially launched the British Innovation Fund II (BIF...
RetinalGeniX Technologies, Inc. Nears Completion of Institutional Review Board for Research on DNA/GPS Program
June 26, 2023 06:15 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today previewed the completion of an Institutional Review Board...
Closing Ceremonies of the YMCA Challenge, supporting the YMCAs of Québec Foundation $155,000 raised to support 900 vulnerable youth!
June 15, 2023 17:36 ET
|
Fondation des YMCA du Québec
MONTREAL, June 15, 2023 (GLOBE NEWSWIRE) -- Making a return as a live, in-person event for the first time since 2019, the YMCA Challenge crushed its objective of $100,000, raising a record $155,000...
Retinalgenix Technologies, Inc. Expands Team to Hasten the Launch of DNA/GPS
June 07, 2023 05:35 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the hiring of Owen Watson, MS. Mr. Watson’s...
The Automated Guided Vehicles Market is projected to grow from USD 2.17 billion in 2022 to USD 4.11 billion by 2030, exhibiting a CAGR of 9.6% during the forecast period.| Data By Contrive Datum Insights Pvt Ltd.
May 11, 2023 17:00 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, May 11, 2023 (GLOBE NEWSWIRE) -- The Global Automated Guided Vehicles Market is projected to grow from USD 2.17 billion in 2022 to USD 4.11 billion by 2030, exhibiting a CAGR of 9.6%...
Endogena Therapeutics Completes Enrollment Ahead of Schedule in its Phase 1/2a Trial of EA-2353 for Retinitis Pigmentosa
May 04, 2023 03:00 ET
|
Endogena
SAN FRANCISCO and TORONTO and ZÜRICH, Switzerland, May 04, 2023 (GLOBE NEWSWIRE) -- Endogena Therapeutics Inc., a clinical-stage biotech company, is pleased to announce that it has completed...